Welcome to our dedicated page for OceanLight Acquisition news (Ticker: OCLT), a resource for investors and traders seeking the latest updates and insights on OceanLight Acquisition stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect OceanLight Acquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of OceanLight Acquisition's position in the market.
OceanLight Acquisition Corporation (OCLT) will allow separate trading of the ordinary shares, rights and warrants included in its IPO units beginning on or about September 11, 2026.
Units that remain combined will continue trading on the Nasdaq Global Market under the symbol OCLTU, while the separated securities are expected to trade under OCLT for ordinary shares, OCLTR for rights and OCLTW for warrants. Holders who wish to separate their units must have their brokers contact Continental Stock Transfer & Trust Company, the transfer agent.
Each unit consists of one ordinary share, one right to receive one-fourth of one ordinary share upon consummation of the company’s initial business combination, and one redeemable warrant. Each whole warrant entitles its holder to purchase one ordinary share at an exercise price of $11.50 per share, subject to adjustment as described in the company’s prospectus.
OceanLight Acquisition Corporation (Nasdaq: OCLTU) announced that underwriters exercised their over-allotment option to purchase an additional 1,500,000 units at $10.00 per unit, increasing total units sold in its IPO to 11,500,000. The over-allotment closing is expected on August 24, 2026, subject to customary conditions.
Each unit comprises one ordinary share, one right to receive one-fourth of one ordinary share upon completion of the initial business combination, and one redeemable warrant. Each whole warrant allows purchase of one ordinary share at an exercise price of $11.50, subject to adjustment. The units trade on the Nasdaq Global Market under ticker OCLTU, with the ordinary shares, rights and warrants expected to trade separately under OCLT, OCLTR and OCLTW, respectively. Polaris Advisory Partners acted as sole book-running manager, and the offering was made under an effective SEC Form S-1 registration.
OceanLight Acquisition Corporation (Nasdaq: OCLTU) has closed its initial public offering of 10,000,000 units at $10.00 per unit. Underwriters hold a 45‑day option to buy up to 1,500,000 additional units at the IPO price to cover any over-allotments.
Each unit includes one ordinary share, one right to receive one-fourth of an ordinary share upon completion of the initial business combination, and one redeemable warrant exercisable at $11.50 per share, subject to adjustment. The units began trading on the Nasdaq Global Market under ticker “OCLTU” on August 7, 2026, with the ordinary shares, rights, and warrants expected to trade separately as “OCLT,” “OCLTR,” and “OCLTW”, respectively.
OceanLight Acquisition Corporation (Nasdaq: OCLTU/OCLT) priced its initial public offering of 10,000,000 units at $10.00 per unit, for an IPO size of approximately $100 million. Each unit includes one ordinary share, one right to receive one-fourth of one ordinary share upon completion of the initial business combination, and one redeemable warrant.
Each whole warrant allows the purchase of one ordinary share at $11.50, subject to adjustments. The units are expected to begin trading on the Nasdaq Global Market under the symbol OCLTU on August 7, 2026, with the IPO expected to close on August 10, 2026, subject to customary conditions. After separation, the ordinary shares, rights and warrants are expected to trade under OCLT, OCLTR and OCLTW, respectively. The underwriters have a 45‑day option to buy up to 1,500,000 additional units to cover over‑allotments.